PerkinElmer
check quantity

AlphaPlate-384, Light gray, untreated, Case of 50

384-well light gray microplates specifically designed for AlphaLISA and AlphaScreen assays.

Part Number
Unit Size
List Price
Your Price
Quantity
6005350
Case of 50
546.00 USD
 
more
6005359
Case of 200
2077.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

PerkinElmer is proud to have designed a light gray microplate which addresses unique challenges of sample screening. Our uniquely engineered 384 well and 1536 well light gray AlphaPlate microplates combine the best features of white microplates (excellent signal-to-background) and black microplates (decreased well-to-well crosstalk) for superior assay window and sensitivity in comparison to any other plate for luminescence assays. Our AlphaPlates are designed for a variety of technologies for luminescence based assays, but are specifically designed for use with PerkinElmer’s AlphaLISA and AlphaScreen technologies.

It’s important to choose the correct microplate prior to your screening project. By choosing the incorrect microplate, challenges such as missed data points, sample re-screening, missed project timelines and ultimately higher costs can be incurred.

Specifications

Automation Compatible Yes
Coating Treatment Untreated
Color Gray
Detection Method Luminescence, Alpha
Material Polystyrene
Product Brand Name AlphaPlate
Shipping Condition Ambient
Sterile No
Unit Size Case of 50
Wells Number 384 well plate
Resources, Events & More
  • All

Application Note

Effects of 5FU and Sorafenib on Proliferation and Biomarker Expression in a Colorectal Cancer Model Using AlphaLISA and EnSight Solutions

A variety of chemotherapeutic drugs with different modes of action have been developed and tested as potential therapies for colorectal cancer. Characterizing the effects of potential drugs with different modes of action is a key part of the process.

In this application note you will learn:

  • How to rapidly measure multiple biomarkers in both cell culture supernatant and lysates from the same wells of a microplate to examine complex protein expression profiles from a colorectal cancer cellular model
  • Benefits of using AlphaLISA® technology for characterizing the effects of potential drugs with different modes of action on a cell culture model of human colorectal cancer
  • How to measure the effects of drug treatments, such as 5FU and Sorafenib, on cellular proliferation by automated well-imaging and cell counting using the EnSight® multimode plate reader
  • Examples of the data and analysis you can generate for such biomarker and proliferation assays

PDF 3 MB